It is often described as a triple hormone receptor agonist because it activates three metabolic receptor systems: GLP-1 GIP Glucagon Semaglutide primarily targets the GLP-1 receptor
While sommarutide is undoubtedly an exciting potential treatment option, there is still a lack of clear clinical data on the mechanism of action of GLP-1 agonists in NASH, such as whether GLP-1 agonists have a direct, independent role in improving NASH, or simply by improving body weight, insulin resistance, and so on
Of the 14 semaglutide-treated patients that developed anti-semaglutide antibodies, 7 patients (0.2% of the overall population) developed antibodies cross-reacting with native GLP-1
Not too bad
Usual causes include: Having large, fatty meals close to the time of your injection
I do think that is pretty cool as we start to see allulose in more and more food products, or it's something that you can buy off the shelf and incorporate and, like I said, it's already in like a certain line of the quest protein bars and it's probably in lots of others